Autologous haematopoietic stem cell transplantation was superior to disease-modifying medications for slowing disability progression.

Takeaway

• Compared with disease-modifying therapies (DMTs), autologous haematopoietic stem cell transplantation halved the risk for confirmed disability progression in patients with clinically active secondary progressive multiple sclerosis.

Why this matters

• Available DMTs have little effect on disability...